TrialMedical oncology (Northwood, London, England)2012

Addition of an induction regimen of antiangiogenesis and antitumor immunity to standard chemotherapy improves survival in advanced malignancies.

Eduardo Lasalvia-Prisco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.